These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

330 related items for PubMed ID: 11685496

  • 1. Striatal dopamine transporter function in dementia with Lewy bodies and Parkinson's disease.
    Ransmayr G, Seppi K, Donnemiller E, Luginger E, Marksteiner J, Riccabona G, Poewe W, Wenning GK.
    Eur J Nucl Med; 2001 Oct; 28(10):1523-8. PubMed ID: 11685496
    [Abstract] [Full Text] [Related]

  • 2. Striatal dopamine transporter in dementia with Lewy bodies and Parkinson disease: a comparison.
    Walker Z, Costa DC, Walker RW, Lee L, Livingston G, Jaros E, Perry R, McKeith I, Katona CL.
    Neurology; 2004 May 11; 62(9):1568-72. PubMed ID: 15136683
    [Abstract] [Full Text] [Related]

  • 3. Striatal DAT and extrastriatal SERT binding in early-stage Parkinson's disease and dementia with Lewy bodies, compared with healthy controls: An 123I-FP-CIT SPECT study.
    Joling M, Vriend C, Raijmakers PGHM, van der Zande JJ, Lemstra AW, Berendse HW, Booij J, van den Heuvel OA.
    Neuroimage Clin; 2019 May 11; 22():101755. PubMed ID: 30884365
    [Abstract] [Full Text] [Related]

  • 4. Correlation of dopamine transporter imaging with parkinsonian motor handicap: how close is it?
    Pirker W.
    Mov Disord; 2003 Oct 11; 18 Suppl 7():S43-51. PubMed ID: 14531046
    [Abstract] [Full Text] [Related]

  • 5. Progression of dopaminergic degeneration in dementia with Lewy bodies and Parkinson's disease with and without dementia assessed using 123I-FP-CIT SPECT.
    Colloby SJ, Williams ED, Burn DJ, Lloyd JJ, McKeith IG, O'Brien JT.
    Eur J Nucl Med Mol Imaging; 2005 Oct 11; 32(10):1176-85. PubMed ID: 15931516
    [Abstract] [Full Text] [Related]

  • 6. 123I-beta-CIT and 123I-IBZM-SPECT scanning in levodopa-naive Parkinson's disease.
    Wenning GK, Donnemiller E, Granata R, Riccabona G, Poewe W.
    Mov Disord; 1998 May 11; 13(3):438-45. PubMed ID: 9613734
    [Abstract] [Full Text] [Related]

  • 7. Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies.
    O'Brien JT, Colloby S, Fenwick J, Williams ED, Firbank M, Burn D, Aarsland D, McKeith IG.
    Arch Neurol; 2004 Jun 11; 61(6):919-25. PubMed ID: 15210531
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Iodine-123-beta-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patients.
    Seibyl JP, Marek K, Sheff K, Zoghbi S, Baldwin RM, Charney DS, van Dyck CH, Innis RB.
    J Nucl Med; 1998 Sep 11; 39(9):1500-8. PubMed ID: 9744331
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [DaT-SCAN SPECT in the differential diagnosis of dementia with Lewy bodies and Alzheimer's disease].
    Vaamonde-Gamo J, Flores-Barragán JM, Ibáñez R, Gudín M, Hernández A.
    Rev Neurol; 1998 Sep 11; 41(5):276-9. PubMed ID: 16138284
    [Abstract] [Full Text] [Related]

  • 12. Iodine-123-N-omega-fluoropropyl-2beta-carbomethoxy-3beta-(4-iod ophenyl)tropane SPECT in healthy controls and early-stage, drug-naive Parkinson's disease.
    Tissingh G, Booij J, Bergmans P, Winogrodzka A, Janssen AG, van Royen EA, Stoof JC, Wolters EC.
    J Nucl Med; 1998 Jul 11; 39(7):1143-8. PubMed ID: 9669384
    [Abstract] [Full Text] [Related]

  • 13. Correlation of Parkinson's disease severity and duration with 123I-FP-CIT SPECT striatal uptake.
    Benamer HT, Patterson J, Wyper DJ, Hadley DM, Macphee GJ, Grosset DG.
    Mov Disord; 2000 Jul 11; 15(4):692-8. PubMed ID: 10928580
    [Abstract] [Full Text] [Related]

  • 14. 123I-FP-CIT SPECT imaging of dopamine transporters in patients with cerebrovascular disease and clinical diagnosis of vascular parkinsonism.
    Lorberboym M, Djaldetti R, Melamed E, Sadeh M, Lampl Y.
    J Nucl Med; 2004 Oct 11; 45(10):1688-93. PubMed ID: 15471834
    [Abstract] [Full Text] [Related]

  • 15. [123I]beta-CIT SPECT imaging assessment of the rate of Parkinson's disease progression.
    Marek K, Innis R, van Dyck C, Fussell B, Early M, Eberly S, Oakes D, Seibyl J.
    Neurology; 2001 Dec 11; 57(11):2089-94. PubMed ID: 11739831
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [[123I]beta-CIT SPECT imaging of dopamine and serotonin transporters in Parkinson's disease and multiple system atrophy.
    Berding G, Brücke T, Odin P, Brooks DJ, Kolbe H, Gielow P, Harke H, Knoop BO, Dengler R, Knapp WH.
    Nuklearmedizin; 2003 Feb 11; 42(1):31-8. PubMed ID: 12601452
    [Abstract] [Full Text] [Related]

  • 18. Differentiation of dementia with Lewy bodies from Alzheimer's disease using a dopaminergic presynaptic ligand.
    Walker Z, Costa DC, Walker RW, Shaw K, Gacinovic S, Stevens T, Livingston G, Ince P, McKeith IG, Katona CL.
    J Neurol Neurosurg Psychiatry; 2002 Aug 11; 73(2):134-40. PubMed ID: 12122169
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Functional morphometry of the striatum in Parkinson's disease on three-dimensional surface display of 123I-beta-CIT SPECT data.
    Ichise M, Kim YJ, Erami SS, Ballinger JR, Vines D, Tanaka F, Lang AE.
    J Nucl Med; 1999 Apr 11; 40(4):530-8. PubMed ID: 10210210
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.